Cargando…

Metastatic HER2+ Breast Cancer: A Potentially Curable Disease?

The advent of trastuzumab and other human epidermal growth factor receptor 2 (HER2)-directed therapies has revolutionized the treatment of metastatic HER2-positive breast cancer, leading to prolonged survival and appreciable clinical benefit for a substantial subset of patients. Previously, in a ret...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prior, Lisa, Lim, Marvin, Ward, Cian, Featherstone, Hannah, Murray, Hazel, D'Arcy, Clare, Crown, John, Gullo, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669532/ https://www.ncbi.nlm.nih.gov/pubmed/29142802 http://dx.doi.org/10.7759/cureus.1654

Ejemplares similares

Whole-exome sequencing of long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancer
por: Walsh, Naomi, et al.
Publicado: (2020)

Clinical and Pathological Complete Remission in a Patient With Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: Is mRCC Curable With Targeted Therapy?
por: Shah, Amishi Y., et al.
Publicado: (2015)

Vera Peters and the curability of Hodgkin disease
por: Cowan, D.H.
Publicado: (2008)

Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approach
por: Fabi, Alessandra, et al.
Publicado: (2022)

A careful reassessment of anthracycline use in curable breast cancer
por: Hurvitz, Sara Alsterlind, et al.
Publicado: (2021)

Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy
por: Ascierto, Maria Libera, et al.
Publicado: (2015)

Treatment Patterns and Outcomes of Elderly Patients With Potentially Curable Esophageal Cancer
por: Yang, Yang, et al.
Publicado: (2022)

Exceptional Responses to Standard Therapy in a Patient with Metastatic HER2-Positive Breast Cancer
por: Nieder, Carsten, et al.
Publicado: (2017)

Efficacy and Safety of Anti-HER2 Agents in Combination With Chemotherapy for Metastatic HER2-Positive Breast Cancer Patient: A Network Meta-Analysis
por: Zhang, Xiaohui, et al.
Publicado: (2021)

PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
por: Fusco, Nicola, et al.
Publicado: (2021)

Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer
por: Ballinger, Tarah J., et al.
Publicado: (2018)

Pyrotinib Combined With Vinorelbine in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study
por: Li, Yi, et al.
Publicado: (2021)

Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort
por: Daniels, Benjamin, et al.
Publicado: (2017)

Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer
por: Gerratana, Lorenzo, et al.
Publicado: (2020)

Differentiation Between Benign and Metastatic Breast Lymph Nodes Using Apparent Diffusion Coefficients
por: Fardanesh, Reza, et al.
Publicado: (2022)

Clinicopathologic features, genomic profiles and outcomes of younger vs. older Chinese hormone receptor-positive (HR+)/HER2-negative (HER2-) metastatic breast cancer patients
por: Wang, Jinhao, et al.
Publicado: (2023)

Expression changes of ER, PR, HER2, and Ki-67 in primary and metastatic breast cancer and its clinical significance
por: Hu, Xueyang, et al.
Publicado: (2023)

Preferences for the sequencing of first-line systemic treatments in metastatic hormone receptor-positive, HER2-negative breast cancer
por: Al Mahmasani, Layal, et al.
Publicado: (2023)

HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients
por: Cavalieri, Stefano, et al.
Publicado: (2023)

A real-world study of anlotinib as third-line or above therapy in patients with her-2 negative metastatic breast cancer
por: Shao, Yingbo, et al.
Publicado: (2022)

Economic evaluation of third-line neratinib plus capecitabine versus lapatinib plus capecitabine with HER2+ metastatic breast cancer
por: Ren, Lanqi, et al.
Publicado: (2023)

Immunotherapy for HER-2 positive breast cancer
por: Yang, Tingting, et al.
Publicado: (2023)

Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer
por: Bae, Soong June, et al.
Publicado: (2021)

Real-world patient characteristics, treatment patterns, and clinical outcomes associated with tucatinib therapy in HER2-positive metastatic breast cancer
por: Kaufman, Peter A., et al.
Publicado: (2023)

Competing mortality risks: predicted cardiovascular disease risk versus predicted risk of breast cancer mortality in patients receiving adjuvant chemotherapy in a single Irish center
por: Prior, Lisa, et al.
Publicado: (2021)

Treatable but not curable cancer in England: a retrospective cohort study using cancer registry data and linked data sets
por: White, Rachel, et al.
Publicado: (2021)

On the Curability of Malignant Tumors of the Breast by Adequate Operations
por: Gross, Samuel W.
Publicado: (1881)

Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study
por: Li, Yi, et al.
Publicado: (2020)

Do body composition parameters correlate with response to targeted therapy in ER+/HER2- metastatic breast cancer patients? Role of sarcopenia and obesity
por: Kripa, Endi, et al.
Publicado: (2022)

Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer: a real-world retrospective study in China
por: Liu, Xiaoyu, et al.
Publicado: (2023)

Insanity Curable
Publicado: (1887)

Meningiomas: Are they curable?
por: Goel, Atul, et al.
Publicado: (2016)

On the Curability of Leprosy
por: Fleming, J. M.
Publicado: (1871)

On the Curability of Leprosy
por: Fleming, J. M.
Publicado: (1871)

On the Curability of Leprosy
por: Fleming, J. M.
Publicado: (1871)

Is Leprosy Curable?
por: Muir, E.
Publicado: (1924)

Is Drunkenness Curable
Publicado: (1892)

Curable Diseases
por: Gibbs, E. H.
Publicado: (1875)

Is Cancer Curable?
por: Gibbs, E. H.
Publicado: (1875)

The Curability of Insanity
Publicado: (1887)

Cannot write session to /tmp/vufind_sessions/sess_b2qjhl58rvd9iqmcm82qomb3bj